- Home
- TAC vs ASH Comparison
TAC vs ASH Comparison
Compare TAC & ASH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TAC
- ASH
- Stock Information
- Founded
- TAC 1909
- ASH 1924
- Country
- TAC Canada
- ASH United States
- Employees
- TAC N/A
- ASH N/A
- Industry
- TAC Electric Utilities: Central
- ASH Specialty Chemicals
- Sector
- TAC Utilities
- ASH Consumer Discretionary
- Exchange
- TAC Nasdaq
- ASH Nasdaq
- Market Cap
- TAC 2.9B
- ASH 2.4B
- IPO Year
- TAC N/A
- ASH N/A
- Fundamental
- Price
- TAC $10.98
- ASH $48.79
- Analyst Decision
- TAC Buy
- ASH Buy
- Analyst Count
- TAC 2
- ASH 5
- Target Price
- TAC $19.75
- ASH $70.75
- AVG Volume (30 Days)
- TAC 1.9M
- ASH 513.0K
- Earning Date
- TAC 07-31-2025
- ASH 08-05-2025
- Dividend Yield
- TAC 1.57%
- ASH 3.42%
- EPS Growth
- TAC N/A
- ASH N/A
- EPS
- TAC 0.00
- ASH N/A
- Revenue
- TAC $1,847,844,992.00
- ASH $1,949,000,000.00
- Revenue This Year
- TAC N/A
- ASH N/A
- Revenue Next Year
- TAC N/A
- ASH $2.35
- P/E Ratio
- TAC $4,788.98
- ASH N/A
- Revenue Growth
- TAC N/A
- ASH N/A
- 52 Week Low
- TAC $6.78
- ASH $45.21
- 52 Week High
- TAC $14.64
- ASH $98.99
- Technical
- Relative Strength Index (RSI)
- TAC 62.37
- ASH 42.93
- Support Level
- TAC $11.19
- ASH $49.38
- Resistance Level
- TAC $11.50
- ASH $54.18
- Average True Range (ATR)
- TAC 0.37
- ASH 1.27
- MACD
- TAC 0.07
- ASH -0.16
- Stochastic Oscillator
- TAC 71.96
- ASH 15.25
About TAC TransAlta Corporation
TransAlta Corp is an independent power producer based in Alberta, Canada. The company operates a diverse and growing fleet of electrical power generation assets in Canada, the United States, and Australia. The company has six reportable segments namely, Hydro, Wind & Solar, Energy Marketing, Gas, Energy Transition segment and Corporate Segment. The company generates the majority of its revenue from the gas segment.
About ASH Ashland Inc.
Ashland Inc is a world-wide specialty materials company that serves a wide range of industrial markets. The company has a business-centric operating model and is organized into four distinct segments: life sciences, personal care, specialty additives, and intermediates. Key customers for the firm include pharmaceutical companies and manufacturers of personal care products, food and beverages, and nutraceuticals and supplements. The life sciences segment derives maximum revenue. The company generates its sales from North America, Europe, Asia Pacific, and Latin America, and Others.